Resources with keywords: Varicella zoster reactivation
Maruki T, et al.
We encountered a patient who developed VZV meningitis shortly after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine.
Maruki T, et al.
We encountered a patient who developed VZV meningitis shortly after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine.